Britain braces as daily weight loss pills hit UK shelves
Britain is bracing for one of the biggest drug launches in its history as the UK's first daily weight loss pills go on sale. Chemists, supermarkets and online clinics report extraordinary pre-launch demand for the oral Wegovy tablet, which costs from about £3 a day privately but is not yet NHS-funded.
From Monday, the first daily GLP-1 weight-loss pills will reach UK patients, just as millions prepare for summer holidays. Doctors stress the medicines are licensed for obesity and weight-related conditions—not cosmetic slimming—yet providers say interest is already surging.
Key Takeaways
- Oral Wegovy is Britain's first daily GLP-1 weight loss pill, using the same semaglutide as injectable Wegovy.
- Superdrug is selling a month's supply from £79 online; SheMed launches oral Wegovy on 7 July after record pre-launch demand.
- Pharmacists report extraordinary interest ahead of launch, with many placing large wholesale orders.
- The pill is licensed privately for eligible adults but has not been approved for NHS use.
- Novo Nordisk is in talks with NICE over potential NHS funding.
Why is Britain bracing for a weight-loss pill stampede?
According to The Telegraph, chemists are braced for one of the biggest drug launches in history as Britain's first daily weight-loss pill goes on sale. Pharmacies, supermarkets and online providers report extraordinary demand before the £3-a-day pills are even widely available, with clinics seeing thousands register interest.
Dr Leyla Hannbeck, chief executive of the Independent Pharmacies Association, said the Wegovy pill is "set to be transformational." She said pharmacists across the country are already seeing significant patient interest, and many pharmacies have placed large orders with wholesalers. The launch is expected to fuel demand among people hoping to lose weight before or during the holiday season.
SheMed, a UK women's health platform, told Reuters it will begin offering oral Wegovy on Tuesday 7 July following record-breaking pre-launch demand. The move reflects growing interest in a needle-free alternative for medically supervised weight management—part of the broader Future Tech & AI Wonders shift toward more accessible treatments.
How much do Wegovy weight loss pills cost privately?
Pricing varies by provider and dose. Superdrug Online Doctor told LBC that a month's supply of the lowest 1.5mg dose starts at £79 for new patients and £99 for existing ones. The 4mg dose costs £99 for new customers and £119 for existing patients, while higher 9mg and 25mg doses are listed as "coming soon" at up to £229 a month.
SheMed is pricing the Wegovy pill at £69 for the first month, with ongoing monthly costs from £154 to £269 depending on dosage, according to its Reuters announcement. The Telegraph reports private providers expect costs from around £3 a day overall—roughly £79 to £99 per month at entry doses.
Who is eligible for the new oral Wegovy tablet?
The Wegovy pill contains semaglutide—the same medicine used in Wegovy injections and the diabetes drug Ozempic—but is taken once daily rather than by weekly injection. It has been licensed for adults who are obese, or those with a body mass index of at least 27 and at least one weight-related health condition.
Both Superdrug and SheMed require a clinical assessment before prescribing. Superdrug asks patients to complete an online questionnaire on weight, height and medical history. SheMed begins each patient journey with at-home blood screening and a clinician review to build a personalised treatment plan.
Will weight loss pills be available on the NHS?
Not yet. The Telegraph reports the medication has not been approved for NHS use, and Novo Nordisk is in talks with the National Institute for Health and Care Excellence over NHS funding if an application goes ahead. Until then, access remains through private prescriptions only.
For official regulatory details on the UK's first GLP-1 tablet approval, see the MHRA announcement on GOV.UK.